Navigation Links
R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
Date:10/6/2009

s release related July 16, 2009 for more information about the Phase I clinical trial.
  • In a double-blind test, for the purpose of conducting the clinical trial in a completely objective manner, the physicians performing the trial as well as the patients participating in the trial do not know if the substance administered to each individual is the drug being tested or the placebo.
  • The placebo is a substance that does not include the drug being tested (RK-023 in this case).
  • About R-Tech Ueno, Ltd.

    R-Tech Ueno was established in September 1989 for the purpose of marketing and R&D of drugs. Under the leadership of the CEO, also a medical doctor, the company is developing new drugs on the theme "Physician-Oriented New Drug Innovation," targeting ophthalmologic and dermatologic diseases that previously had no effective therapeutic agent. The company's main product Rescula(R) eyedrop 0.12% is a therapeutic drug for glaucoma and ocular hypertension and has been marketed in Japan since 1994. R-Tech Ueno was the first in the world to take advantage of the substance "prostone" in the development of Rescula(R). Prostone was discovered in 1980 by Dr. Ryuji Ueno, the founder of the company. Rescula(R) eyedrop 0.12% that causes less topical and systemic adverse reactions demonstrates steady ocular pressure-decreasing action by twice-a-day instillation. Such excellent therapeutic effects are realized through its optic nerve protection and ocular blood flow-increasing mechanism.

        Stock Code: No.4573, Osaka Securities Exchange; Hercules
        Head Office: 1-1-7 Uchisaiwai-cho, Chiyoda-ku, Tokyo
        Representative Director & President: Yukihiko Mashima
    
    
        Contact:
        Koji Nakamura,
        Business Management Department
        R-Tech Ueno, Ltd.
        Tel: +81-3-3596-8011
        e-mail: koji.nakamura@rtueno.co.jp
        URL: '/>"/>
    SOURCE R-Tech Ueno, Ltd.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
    2. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
    3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
    4. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
    5. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
    6. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
    7. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
    8. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
    9. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
    10. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
    11. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... and LYON, France , Dec. 19, ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ADOC) ... an ultra-rapid insulin, known as BioChaperone Lispro, for treatment ... BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology and ... and Adocia will develop BioChaperone Lispro with the goal ...
    (Date:12/17/2014)... , Dec. 17, 2014  Strategic Health Services, Inc. ... solutions, today announced a strategic agreement with QualCare, Inc., a ... New Jersey regional marketplace.  This agreement will ... health and wellness solutions QualCare brings to its clients ... surrounding region. QualCare plans cover more ...
    (Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, ... US Patent and Trademark Office (USPTO) has issued ... a dendritic cell-based immunotherapeutic vaccine targeting six tumor ... claims of US Patent No. 8,871,211, which issued ... cancer by administering a dendritic cell composition comprising ...
    Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
    ... 2011 Reportlinker.com announces that a ... in its catalogue: ... Global Markets ... HIGHLIGHTS * The ...
    ... The Commonwealth on Wednesday welcomed a ... global action against the burden and debilitating impact of ... Commonwealth priorities as identified by Health Ministers at their ... Priority for the Commonwealth". The High-Level  Meeting ...
    Cached Medicine Technology:Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 2Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 3Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 4Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 5Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 6Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 7Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 8Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 9Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 10Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 11Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 12Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 13Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 14Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 15Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 16Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 17Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 18Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 19Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 20Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 21Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 22Commonwealth Welcomes Global Commitment to Combat Non-Communicable Diseases 2
    (Date:12/21/2014)... BellasDress.com offers a wide range of women’s dresses, ... its BellasDress Christmas Sale , offering big discounts ... BellasDress is a famous online supplier of women’s dresses; ... series of promotions. The dress experts of the company ... are proud of offering high quality wedding dresses and ...
    (Date:12/21/2014)... York, New York (PRWEB) December 21, 2014 ... ) and other product liability claims involving a ... incretin mimetics continue to move forward in a ... Court, Southern District of California, Bernstein Liebhard LLP ... the Court has established a data cut-off date ...
    (Date:12/21/2014)... Muskegon, Mi (PRWEB) December 21, 2014 ... a child in need while at the same time helping ... is a non-profit community-based organization committed to serving those ... to meet their needs to improve the quality of life. ... would make an impact in the local community and he ...
    (Date:12/21/2014)... Portland, OR (PRWEB) December 21, 2014 ... discussing some of the issues and systemic barriers for ... ITU World Paratriathlon Champion. Scheidies has a condition called ... over time. He describes how he adapted his athletic ... to use his success in triathlon to pioneer the ...
    (Date:12/21/2014)... (PRWEB) December 21, 2014 The Oncology Institute ... in the Santa Ana and Whittier offices. The Hope for ... the lives of patients and their families during the holiday ... out to approximately 70 children between both offices. This event ... help of Target’s community service team, store managers and assistant ...
    Breaking Medicine News(10 mins):Health News:BellasDress.com Announces its BellasDress Christmas Sale 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3
    ... identified some of the elusive downstream molecules that play a ... cancer. The research, published by Cell Press in the October ... identifies a compound found in grapes and red wine as ... cancer. , About 8% of breast cancer cases are caused ...
    ... by Johns Hopkins Children,s Center challenge the longstanding practice ... to fight inflammation and prevent lung disease. The researchers ... and that low cortisol levels are not even necessarily ... to increase the risk of dangerous bleeding in the ...
    ... 9 Miss Universe 2008 Dayana,Mendoza demonstrates her commitment ... HIV at the 6th annual National Latino AIDS Awareness,Day ... at the Julia de Burgos,Cultural Center located at 1680 ... impact of the epidemic continues to disproportionately affect the,health ...
    ... their lives with social change, are failing to break ... Academic research supported by the Economic and Social Research ... most members of the baby boom generation often ... consumer society - have modest ideas for their retirement. ...
    ... Life Spine, HOFFMAN ESTATES, Ill., Oct. 8 ... that it has acquired the,majority of the intellectual property ... disclosed., According to Michael S. Butler, Life Spine,s ... of the spine market,place is intellectual property. To this ...
    ... About John McCain,s Health Care Plan" a Blockbuster in Swing,States, ... DVD "The Facts about John McCain,s Health Care Plan" have ... weeks, courtesy of the,Service Employees International Union (SEIU). The DVD ... -- Voting against helping seniors afford the prescription ...
    Cached Medicine News:Health News:New findings may improve treatment of inherited breast cancer 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 3Health News:Miss Universe 2008 Dayana Mendoza Joins the Fight Against AIDS by Getting Tested for HIV 2Health News:Miss Universe 2008 Dayana Mendoza Joins the Fight Against AIDS by Getting Tested for HIV 3Health News:'60s generation is heading for conventional old age 2Health News:'60s generation is heading for conventional old age 3Health News:'60s generation is heading for conventional old age 4Health News:SEIU DVD Exposes How McCain 'Care' Leaves Seniors Behind 2
    10 L, Bulk Recommended for 2, 5, 10 L pipettes....
    This extended 10 ul combats contamination by keeping your pipettor out of 1.5 ul and 2.0 ul tubes. Utilizes MicroPoint design and 2 ul reference mark....
    ... the gold standard for WBC differentials, ... your technologists manual results- no doubts, ... morphology advances cell separation to a ... differentiation of various disease states, including ...
    200 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
    Medicine Products: